The potential impact of CAR T-cell treatment delays on society.
CONCLUSIONS: The social value of CAR T is significantly limited by treatment delays. Efficient payment mechanisms, adequate capital, and payment policy reform are urgently needed to increase patient access and maximize the value of CAR T.
PMID: 31419095 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Thornton Snider J, Brauer M, Kee R, Batt K, Karaca-Mandic P, Zhang J, Goldman DP Tags: Am J Manag Care Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Health Management | Leukemia | Lymphoma | Managed Care | Pediatrics | Study | USA Health